ID   ENOB_RAT                Reviewed;         434 AA.
AC   P15429; Q5XIV3;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   29-MAY-2024, entry version 187.
DE   RecName: Full=Beta-enolase;
DE            EC=4.2.1.11 {ECO:0000269|PubMed:8594891};
DE   AltName: Full=2-phospho-D-glycerate hydro-lyase;
DE   AltName: Full=Enolase 3;
DE   AltName: Full=Muscle-specific enolase;
DE            Short=MSE;
DE   AltName: Full=Skeletal muscle enolase;
GN   Name=Eno3; Synonyms=Eno-3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Skeletal muscle;
RX   PubMed=2914621; DOI=10.1016/0014-5793(89)80515-0;
RA   Ohshima Y., Mitsui H., Takayama Y., Kushiya E., Sakimura K., Takahashi Y.;
RT   "cDNA cloning and nucleotide sequence of rat muscle-specific enolase (beta
RT   beta enolase).";
RL   FEBS Lett. 242:425-430(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28.
RX   PubMed=2269373; DOI=10.1016/0014-5793(90)80813-x;
RA   Sakimura K., Kushiya E., Ohshima-Ichimura Y., Mitsui H., Takahashi Y.;
RT   "Structure and expression of rat muscle-specific enolase gene.";
RL   FEBS Lett. 277:78-82(1990).
RN   [4]
RP   PROTEIN SEQUENCE OF 10-28; 33-50; 106-120; 240-253; 257-262; 336-394 AND
RP   407-412, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [5]
RP   DEVELOPMENTAL STAGE, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=8594891; DOI=10.1152/ajpheart.1995.269.6.h1843;
RA   Keller A., Rouzeau J.-D., Farhadian F., Wisnewsky C., Marotte F.,
RA   Lamande N., Samuel J.L., Schwartz K., Lazar M., Lucas M.;
RT   "Differential expression of alpha- and beta-enolase genes during rat heart
RT   development and hypertrophy.";
RL   Am. J. Physiol. 269:H1843-H1851(1995).
RN   [6]
RP   EFFECT OF THYROID HORMONES ON EXPRESSION.
RX   PubMed=10662718; DOI=10.1152/ajpendo.2000.278.2.e330;
RA   Merkulova T., Keller A., Oliviero P., Marotte F., Samuel J.L.,
RA   Rappaport L., Lamande N., Lucas M.;
RT   "Thyroid hormones differentially modulate enolase isozymes during rat
RT   skeletal and cardiac muscle development.";
RL   Am. J. Physiol. 278:E330-E339(2000).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-72; SER-83; SER-157; THR-205;
RP   THR-229; TYR-236 AND SER-263, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-
CC       phosphoglycerate to phosphoenolpyruvate. Appears to have a function in
CC       striated muscle development and regeneration.
CC       {ECO:0000269|PubMed:8594891}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-2-phosphoglycerate = H2O + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:10164, ChEBI:CHEBI:15377, ChEBI:CHEBI:58289,
CC         ChEBI:CHEBI:58702; EC=4.2.1.11;
CC         Evidence={ECO:0000269|PubMed:8594891};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10165;
CC         Evidence={ECO:0000305|PubMed:8594891};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Mg(2+) is required for catalysis and for stabilizing the dimer.;
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 4/5. {ECO:0000305|PubMed:8594891}.
CC   -!- SUBUNIT: Mammalian enolase is composed of 3 isozyme subunits, alpha,
CC       beta and gamma, which can form homodimers or heterodimers which are
CC       cell-type and development-specific. Interacts with PNKD (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P15429; Q5VU43-11: PDE4DIP; Xeno; NbExp=2; IntAct=EBI-10817548, EBI-10769071;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Localized to the Z line. Some
CC       colocalization with CKM at M-band (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: The alpha/alpha homodimer is expressed in embryo
CC       and in most adult tissues. The alpha/beta heterodimer and the beta/beta
CC       homodimer are found in striated muscle, and the alpha/gamma heterodimer
CC       and the gamma/gamma homodimer in neurons.
CC   -!- DEVELOPMENTAL STAGE: During ontogenesis, there is a transition from the
CC       alpha/alpha homodimer to the alpha/beta heterodimer in striated muscle
CC       cells. {ECO:0000269|PubMed:8594891}.
CC   -!- INDUCTION: Thyroid hormones up-regulate expression during hindleg
CC       muscle development and down-regulate during cardiac muscle development.
CC       Decrease in ENO3 levels with aortic stenosis.
CC   -!- SIMILARITY: Belongs to the enolase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00979; CAA68788.1; -; mRNA.
DR   EMBL; BC083566; AAH83566.1; -; mRNA.
DR   EMBL; X57774; CAA40920.1; -; Genomic_DNA.
DR   PIR; S02072; S02072.
DR   RefSeq; NP_037081.2; NM_012949.2.
DR   RefSeq; XP_006246661.1; XM_006246599.3.
DR   RefSeq; XP_006246662.1; XM_006246600.3.
DR   AlphaFoldDB; P15429; -.
DR   SMR; P15429; -.
DR   BioGRID; 247473; 2.
DR   IntAct; P15429; 1.
DR   STRING; 10116.ENSRNOP00000005612; -.
DR   GlyGen; P15429; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P15429; -.
DR   PhosphoSitePlus; P15429; -.
DR   SwissPalm; P15429; -.
DR   jPOST; P15429; -.
DR   PaxDb; 10116-ENSRNOP00000005612; -.
DR   Ensembl; ENSRNOT00000005612.7; ENSRNOP00000005612.4; ENSRNOG00000004078.8.
DR   Ensembl; ENSRNOT00055052032; ENSRNOP00055042968; ENSRNOG00055030014.
DR   Ensembl; ENSRNOT00060042934; ENSRNOP00060035551; ENSRNOG00060024787.
DR   Ensembl; ENSRNOT00065050442; ENSRNOP00065041457; ENSRNOG00065029192.
DR   GeneID; 25438; -.
DR   KEGG; rno:25438; -.
DR   UCSC; RGD:2555; rat.
DR   AGR; RGD:2555; -.
DR   CTD; 2027; -.
DR   RGD; 2555; Eno3.
DR   eggNOG; KOG2670; Eukaryota.
DR   GeneTree; ENSGT00950000182805; -.
DR   HOGENOM; CLU_031223_0_0_1; -.
DR   InParanoid; P15429; -.
DR   OMA; RHIADIS; -.
DR   OrthoDB; 1093250at2759; -.
DR   PhylomeDB; P15429; -.
DR   TreeFam; TF300391; -.
DR   Reactome; R-RNO-70171; Glycolysis.
DR   Reactome; R-RNO-70263; Gluconeogenesis.
DR   UniPathway; UPA00109; UER00187.
DR   PRO; PR:P15429; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000004078; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0000015; C:phosphopyruvate hydratase complex; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004634; F:phosphopyruvate hydratase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0061621; P:canonical glycolysis; ISO:RGD.
DR   GO; GO:0006096; P:glycolytic process; IBA:GO_Central.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEP:RGD.
DR   CDD; cd03313; enolase; 1.
DR   Gene3D; 3.20.20.120; Enolase-like C-terminal domain; 1.
DR   Gene3D; 3.30.390.10; Enolase-like, N-terminal domain; 1.
DR   HAMAP; MF_00318; Enolase; 1.
DR   InterPro; IPR000941; Enolase.
DR   InterPro; IPR036849; Enolase-like_C_sf.
DR   InterPro; IPR029017; Enolase-like_N.
DR   InterPro; IPR020810; Enolase_C.
DR   InterPro; IPR020809; Enolase_CS.
DR   InterPro; IPR020811; Enolase_N.
DR   NCBIfam; TIGR01060; eno; 1.
DR   PANTHER; PTHR11902:SF5; BETA-ENOLASE; 1.
DR   PANTHER; PTHR11902; ENOLASE; 1.
DR   Pfam; PF00113; Enolase_C; 1.
DR   Pfam; PF03952; Enolase_N; 1.
DR   PIRSF; PIRSF001400; Enolase; 1.
DR   PRINTS; PR00148; ENOLASE.
DR   SFLD; SFLDS00001; Enolase; 1.
DR   SFLD; SFLDF00002; enolase; 1.
DR   SMART; SM01192; Enolase_C; 1.
DR   SMART; SM01193; Enolase_N; 1.
DR   SUPFAM; SSF51604; Enolase C-terminal domain-like; 1.
DR   SUPFAM; SSF54826; Enolase N-terminal domain-like; 1.
DR   PROSITE; PS00164; ENOLASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Direct protein sequencing; Glycolysis; Lyase;
KW   Magnesium; Metal-binding; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P13929"
FT   CHAIN           2..434
FT                   /note="Beta-enolase"
FT                   /id="PRO_0000134110"
FT   ACT_SITE        210
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        343
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         158
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         167
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         245
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         293
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         293
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         318
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         318
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         370..373
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         394
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P13929"
FT   MOD_RES         72
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         83
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         157
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P13929"
FT   MOD_RES         205
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         229
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         236
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        63
FT                   /note="L -> P (in Ref. 1; CAA68788)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176..182
FT                   /note="SSFKEAM -> KLFQGSQ (in Ref. 1; CAA68788)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        279
FT                   /note="L -> P (in Ref. 1; CAA68788)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        355
FT                   /note="Q -> L (in Ref. 1; CAA68788)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        381
FT                   /note="I -> V (in Ref. 1; CAA68788)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   434 AA;  47014 MW;  136A5300E052D5A7 CRC64;
     MAMQKIFARE ILDSRGNPTV EVDLHTAKGR FRAAVPSGAS TGIYEALELR DGDKSRYLGK
     GVLKAVEHIN KTLGPALLEK KLSVVDQEKV DKFMIELDGT ENKSKFGANA ILGVSLAVCK
     AGAAEKGVPL YRHIADLAGN PDLVLPVPAF NVINGGSHAG NKLAMQEFMI LPVGASSFKE
     AMRIGAEVYH HLKGVIKAKY GKDATNVGDE GGFAPNILEN NEALELLKTA IQAAGYPDKV
     VIGMDVAASE FYRNGKYDLD FKSPDDPARH ISGEKLGELY KSFIKNYPVV SIEDPFDQDD
     WATWTSFLSG VDIQIVGDDL TVTNPKRIAQ AVEKKACNCL LLKVNQIGSV TESIQACKLA
     QSNGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL MRIEEALGDK
     AVFAGRKFRN PKAK
//
